Than P, Yao S, Althagafi E, Kaur K
ACS Med Chem Lett. 2025; 16(1):109-115.
PMID: 39811122
PMC: 11726362.
DOI: 10.1021/acsmedchemlett.4c00480.
Topley M, Sparks P, Crotty A, Kawaja M, Hendry J
Muscle Nerve. 2024; 71(1):113-123.
PMID: 39529451
PMC: 11632577.
DOI: 10.1002/mus.28291.
Xu S, Wang H, Zhu Y, Han Y, Liu L, Zhang X
Int J Oral Sci. 2024; 16(1):47.
PMID: 38945975
PMC: 11214941.
DOI: 10.1038/s41368-024-00311-1.
Kubo T, Nishimura N, Kaji K, Tomooka F, Shibamoto A, Iwai S
Int J Mol Sci. 2024; 25(8).
PMID: 38673992
PMC: 11050651.
DOI: 10.3390/ijms25084405.
ONeill C, Sun K, Sundararaman S, Chang J, Glynn S
Front Physiol. 2024; 15:1358850.
PMID: 38601214
PMC: 11004480.
DOI: 10.3389/fphys.2024.1358850.
Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance.
Sunaga N, Miura Y, Masuda T, Sakurai R
Cancers (Basel). 2024; 16(4).
PMID: 38398101
PMC: 10886815.
DOI: 10.3390/cancers16040710.
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable Link.
Effenberger M, Grander C, Grabherr F, Tilg H
J Clin Transl Hepatol. 2024; 11(7):1498-1507.
PMID: 38161503
PMC: 10752805.
DOI: 10.14218/JCTH.2023.00069.
Integrated analysis of EREG expression, a gene associated with cervical cancer prognosis.
Yang S, Yang X, Li C
Am J Cancer Res. 2023; 13(10):4644-4660.
PMID: 37970371
PMC: 10636660.
Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction.
Jehl A, Conrad O, Burgy M, Foppolo S, Vauchelles R, Ronzani C
Cells. 2023; 12(5).
PMID: 36899869
PMC: 10000618.
DOI: 10.3390/cells12050733.
Sentinel cells in the basement membrane form a reparative niche in the lung.
Reyes N, Krasilnikov M, Allen N, Lee J, Hyams B, Zhou M
Science. 2022; 378(6616):192-201.
PMID: 36227993
PMC: 10621323.
DOI: 10.1126/science.abf3326.
Hyperstable EGF-like bleogen derived from cactus accelerates corneal healing in rats.
Loo S, Kam A, Tam J
Front Pharmacol. 2022; 13:942168.
PMID: 36052138
PMC: 9424907.
DOI: 10.3389/fphar.2022.942168.
Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
Hyun J, Kim S, Yoon S, Lee S, Jeong J, Gupta H
Int J Mol Sci. 2022; 23(15).
PMID: 35955885
PMC: 9368757.
DOI: 10.3390/ijms23158749.
The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective.
Wang L, Cao Z, Zhang L, Li J, Lv W
Front Immunol. 2022; 13:923599.
PMID: 35911738
PMC: 9326173.
DOI: 10.3389/fimmu.2022.923599.
The homeostatic malfunction of a novel feedback pathway formed by lncRNA021545, miR-330-3p and epiregulin contributes in hepatocarcinoma progression via mediating epithelial-mesenchymal transition.
Yang S, Zhang Y, Guo C, Liu R, Elkharti M, Ge Z
Am J Cancer Res. 2022; 12(6):2492-2525.
PMID: 35812040
PMC: 9251696.
Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity.
Song N, Lee A, Yasmeen R, Shen Q, Yang K, Kumar S
Cells. 2022; 11(3).
PMID: 35159237
PMC: 8834548.
DOI: 10.3390/cells11030425.
The Role of EREG/EGFR Pathway in Tumor Progression.
Cheng W, Feng P, Lee K, Chen K, Sun W, Van Hiep N
Int J Mol Sci. 2021; 22(23).
PMID: 34884633
PMC: 8657471.
DOI: 10.3390/ijms222312828.
A Novel DNA Replication-Related Signature Predicting Recurrence After R0 Resection of Pancreatic Ductal Adenocarcinoma: Prognostic Value and Clinical Implications.
Feng Z, Li K, Lou J, Ma M, Wu Y, Peng C
Front Cell Dev Biol. 2021; 9:619549.
PMID: 33748108
PMC: 7969722.
DOI: 10.3389/fcell.2021.619549.
Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs.
Ikeda H, Uchida H, Okubo Y, Shibata T, Sasaki Y, Suzuki T
J Virol. 2021; 95(9).
PMID: 33627393
PMC: 8104110.
DOI: 10.1128/JVI.01766-20.
Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.
Schurmann M, Oppel F, Shao S, Volland-Thurn V, Kaltschmidt C, Kaltschmidt B
Cell Commun Signal. 2021; 19(1):25.
PMID: 33627146
PMC: 7903614.
DOI: 10.1186/s12964-020-00690-y.
EREG-driven oncogenesis of Head and Neck Squamous Cell Carcinoma exhibits higher sensitivity to Erlotinib therapy.
Liu S, Wang Y, Han Y, Xia W, Zhang L, Xu S
Theranostics. 2020; 10(23):10589-10605.
PMID: 32929368
PMC: 7482801.
DOI: 10.7150/thno.47176.